Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis

Corneli, Howard M., Zorc, Joseph J., Mahajan, Prashant, Shaw, Kathy N., Holubkov, Richard, Reeves, Scott D., Ruddy, Richard M., Malik, Baqir, Nelson, Kyle A., Bregstein, Joan S., Brown, Kathleen M., Denenberg, Matthew N., Lillis, Kathleen A., Cimpello, Lynn Babcock, Tsung, James W., Borgialli, Dominic A., Baskin, Marc N., Teshome, Getachew, Goldstein, Mitchell A., Monroe, David, Dean, J. Michael, Kuppermann, Nathan · 2007 · New England Journal of Medicine

Abstract

BACKGROUND: Bronchiolitis, the most common infection of the lower respiratory tract in infants, is a leading cause of hospitalization in childhood. Corticosteroids are commonly used to treat bronchiolitis, but evidence of their effectiveness is limited. METHODS: We conducted a double-blind, randomized trial comparing a single dose of oral dexamethasone (1 mg per kilogram of body weight) with placebo in 600 children (age range, 2 to 12 months) with a first episode of wheezing diagnosed in the emergency department as moderate-to-severe bronchiolitis (defined by a Respiratory Distress Assessment Instrument score > or =6). We enrolled patients at 20 emergency departments during the months of November through April over a 3-year period. The primary outcome was hospital admission after 4 hours of emergency department observation. The secondary outcome was the Respiratory Assessment Change Score (RACS). We also evaluated later outcomes: length of hospital stay, later medical visits or admissions, and adverse events. RESULTS: Baseline characteristics were similar in the two groups. The admission rate was 39.7% for children assigned to dexamethasone, as compared with 41.0% for those assigned to placebo (absolute difference, -1.3%; 95% confidence interval [CI], -9.2 to 6.5). Both groups had respiratory improvement during observation; the mean 4-hour RACS was -5.3 for dexamethasone, as compared with -4.8 for placebo (absolute difference, -0.5; 95% CI, -1.3 to 0.3). Multivariate adjustment did not significantly alter the results, nor were differences detected in later outcomes. CONCLUSIONS: In infants with acute moderate-to-severe bronchiolitis who were treated in the emergency department, a single dose of 1 mg of oral dexamethasone per kilogram did not significantly alter the rate of hospital admission, the respiratory status after 4 hours of observation, or later outcomes. (ClinicalTrials.gov number, NCT00119002 [ClinicalTrials.gov].).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa071255

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 290

Metadata

Authors
Corneli, H. M., Zorc, J. J., Mahajan, P., Shaw, K. N., Holubkov, R., Reeves, S. D., Ruddy, R. M., Malik, B., Nelson, K. A., Bregstein, J. S., Brown, K. M., Denenberg, M. N., Lillis, K. A., Cimpello, L. B., Tsung, J. W., Borgialli, D. A., Baskin, M. N., Teshome, G., Goldstein, M. A., Monroe, D., Dean, J. M., & Kuppermann, N.
Venue
New England Journal of Medicine
Published
2007-07-26
Volume
357
Issue
4
Pages
331-339
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2138691565
Cited by
290
References
18
FWCI
17.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis. https://app.cochat.ai/papers/10.1056/nejmoa071255
The paper
Corneli, H. M., Zorc, J. J., Mahajan, P., Shaw, K. N., Holubkov, R., Reeves, S. D., Ruddy, R. M., Malik, B., Nelson, K. A., Bregstein, J. S., Brown, K. M., Denenberg, M. N., Lillis, K. A., Cimpello, L. B., Tsung, J. W., Borgialli, D. A., Baskin, M. N., Teshome, G., Goldstein, M. A., . . . Kuppermann, N. (2007). A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa071255

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.